Cargando…

Neuroprotective and Angiogenesis Effects of Levetiracetam Following Ischemic Stroke in Rats

Objective: The present study explored whether levetiracetam (LEV) could protect against experimental brain ischemia and enhance angiogenesis in rats, and investigated the potential mechanisms in vivo and in vitro. Methods: The middle cerebral artery was occluded for 60 min to induce middle cerebral...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Xiang, Yang, Wenping, Ren, Zhendong, Zhang, Haoran, Shi, Dafa, Li, Yanfei, Yu, Ziyang, Guo, Qiu, Yang, Guangwei, Gu, Yingjiang, Zhao, Hairong, Ren, Ke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161206/
https://www.ncbi.nlm.nih.gov/pubmed/34054520
http://dx.doi.org/10.3389/fphar.2021.638209
_version_ 1783700455625326592
author Yao, Xiang
Yang, Wenping
Ren, Zhendong
Zhang, Haoran
Shi, Dafa
Li, Yanfei
Yu, Ziyang
Guo, Qiu
Yang, Guangwei
Gu, Yingjiang
Zhao, Hairong
Ren, Ke
author_facet Yao, Xiang
Yang, Wenping
Ren, Zhendong
Zhang, Haoran
Shi, Dafa
Li, Yanfei
Yu, Ziyang
Guo, Qiu
Yang, Guangwei
Gu, Yingjiang
Zhao, Hairong
Ren, Ke
author_sort Yao, Xiang
collection PubMed
description Objective: The present study explored whether levetiracetam (LEV) could protect against experimental brain ischemia and enhance angiogenesis in rats, and investigated the potential mechanisms in vivo and in vitro. Methods: The middle cerebral artery was occluded for 60 min to induce middle cerebral artery occlusion (MCAO). The Morris water maze was used to measure cognitive ability. The rotation test was used to assess locomotor function. T2-weighted MRI was used to assess infarct volume. The neuronal cells in the cortex area were stained with cresyl purple. The anti-inflammatory effects of LEV on microglia were observed by immunohistochemistry. Enzyme-linked immunosorbent assays (ELISA) were used to measure the production of pro-inflammatory cytokines. Western blotting was used to detect the levels of heat shock protein 70 (HSP70), vascular endothelial growth factor (VEGF), and hypoxia-inducible factor-1α (HIF-1α) in extracts from the ischemic cortex. Flow cytometry was used to observe the effect of LEV on neuronal cell apoptosis. Results: LEV treatment significantly increased the density of the surviving neurons in the cerebral cortex and reduced the infarct size (17.8 ± 3.3% vs. 12.9 ± 1.4%, p < 0.01) after MCAO. Concurrently, the time required to reach the platform for LEV-treated rats was shorter than that in the saline group on day 11 after MCAO (p < 0.01). LEV treatment prolonged the rotarod retention time on day 14 after MCAO (84.5 ± 6.7 s vs. 59.1 ± 6.2 s on day 14 compared with the saline-treated groups, p < 0.01). It also suppressed the activation of microglia and inhibited TNF-α and Il-1β in the ischemic brain (135.6 ± 5.2 pg/ml vs. 255.3 ± 12.5 pg/ml, 18.5 ± 1.3 pg/ml vs. 38.9 ± 2.3 pg/ml on day 14 compared with the saline-treated groups, p < 0.01). LEV treatment resulted in a significant increase in HIF-1α, VEGF, and HSP70 levels in extracts from the ischemic cerebral cortex. At the same time, LEV reduced neuronal cell cytotoxicity and apoptosis induced by an ischemic stroke (p < 0.01). Conclusion: LEV treatment promoted angiogenesis and functional recovery after cerebral ischemia in rats. These effects seem to be mediated through anti-inflammatory and antiapoptotic activities, as well as inducing the expression of HSP70, VEGF, and HIF-1α.
format Online
Article
Text
id pubmed-8161206
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-81612062021-05-29 Neuroprotective and Angiogenesis Effects of Levetiracetam Following Ischemic Stroke in Rats Yao, Xiang Yang, Wenping Ren, Zhendong Zhang, Haoran Shi, Dafa Li, Yanfei Yu, Ziyang Guo, Qiu Yang, Guangwei Gu, Yingjiang Zhao, Hairong Ren, Ke Front Pharmacol Pharmacology Objective: The present study explored whether levetiracetam (LEV) could protect against experimental brain ischemia and enhance angiogenesis in rats, and investigated the potential mechanisms in vivo and in vitro. Methods: The middle cerebral artery was occluded for 60 min to induce middle cerebral artery occlusion (MCAO). The Morris water maze was used to measure cognitive ability. The rotation test was used to assess locomotor function. T2-weighted MRI was used to assess infarct volume. The neuronal cells in the cortex area were stained with cresyl purple. The anti-inflammatory effects of LEV on microglia were observed by immunohistochemistry. Enzyme-linked immunosorbent assays (ELISA) were used to measure the production of pro-inflammatory cytokines. Western blotting was used to detect the levels of heat shock protein 70 (HSP70), vascular endothelial growth factor (VEGF), and hypoxia-inducible factor-1α (HIF-1α) in extracts from the ischemic cortex. Flow cytometry was used to observe the effect of LEV on neuronal cell apoptosis. Results: LEV treatment significantly increased the density of the surviving neurons in the cerebral cortex and reduced the infarct size (17.8 ± 3.3% vs. 12.9 ± 1.4%, p < 0.01) after MCAO. Concurrently, the time required to reach the platform for LEV-treated rats was shorter than that in the saline group on day 11 after MCAO (p < 0.01). LEV treatment prolonged the rotarod retention time on day 14 after MCAO (84.5 ± 6.7 s vs. 59.1 ± 6.2 s on day 14 compared with the saline-treated groups, p < 0.01). It also suppressed the activation of microglia and inhibited TNF-α and Il-1β in the ischemic brain (135.6 ± 5.2 pg/ml vs. 255.3 ± 12.5 pg/ml, 18.5 ± 1.3 pg/ml vs. 38.9 ± 2.3 pg/ml on day 14 compared with the saline-treated groups, p < 0.01). LEV treatment resulted in a significant increase in HIF-1α, VEGF, and HSP70 levels in extracts from the ischemic cerebral cortex. At the same time, LEV reduced neuronal cell cytotoxicity and apoptosis induced by an ischemic stroke (p < 0.01). Conclusion: LEV treatment promoted angiogenesis and functional recovery after cerebral ischemia in rats. These effects seem to be mediated through anti-inflammatory and antiapoptotic activities, as well as inducing the expression of HSP70, VEGF, and HIF-1α. Frontiers Media S.A. 2021-05-14 /pmc/articles/PMC8161206/ /pubmed/34054520 http://dx.doi.org/10.3389/fphar.2021.638209 Text en Copyright © 2021 Yao, Yang, Ren, Zhang, Shi, Li, Yu, Guo, Yang, Gu, Zhao and Ren. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Yao, Xiang
Yang, Wenping
Ren, Zhendong
Zhang, Haoran
Shi, Dafa
Li, Yanfei
Yu, Ziyang
Guo, Qiu
Yang, Guangwei
Gu, Yingjiang
Zhao, Hairong
Ren, Ke
Neuroprotective and Angiogenesis Effects of Levetiracetam Following Ischemic Stroke in Rats
title Neuroprotective and Angiogenesis Effects of Levetiracetam Following Ischemic Stroke in Rats
title_full Neuroprotective and Angiogenesis Effects of Levetiracetam Following Ischemic Stroke in Rats
title_fullStr Neuroprotective and Angiogenesis Effects of Levetiracetam Following Ischemic Stroke in Rats
title_full_unstemmed Neuroprotective and Angiogenesis Effects of Levetiracetam Following Ischemic Stroke in Rats
title_short Neuroprotective and Angiogenesis Effects of Levetiracetam Following Ischemic Stroke in Rats
title_sort neuroprotective and angiogenesis effects of levetiracetam following ischemic stroke in rats
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161206/
https://www.ncbi.nlm.nih.gov/pubmed/34054520
http://dx.doi.org/10.3389/fphar.2021.638209
work_keys_str_mv AT yaoxiang neuroprotectiveandangiogenesiseffectsoflevetiracetamfollowingischemicstrokeinrats
AT yangwenping neuroprotectiveandangiogenesiseffectsoflevetiracetamfollowingischemicstrokeinrats
AT renzhendong neuroprotectiveandangiogenesiseffectsoflevetiracetamfollowingischemicstrokeinrats
AT zhanghaoran neuroprotectiveandangiogenesiseffectsoflevetiracetamfollowingischemicstrokeinrats
AT shidafa neuroprotectiveandangiogenesiseffectsoflevetiracetamfollowingischemicstrokeinrats
AT liyanfei neuroprotectiveandangiogenesiseffectsoflevetiracetamfollowingischemicstrokeinrats
AT yuziyang neuroprotectiveandangiogenesiseffectsoflevetiracetamfollowingischemicstrokeinrats
AT guoqiu neuroprotectiveandangiogenesiseffectsoflevetiracetamfollowingischemicstrokeinrats
AT yangguangwei neuroprotectiveandangiogenesiseffectsoflevetiracetamfollowingischemicstrokeinrats
AT guyingjiang neuroprotectiveandangiogenesiseffectsoflevetiracetamfollowingischemicstrokeinrats
AT zhaohairong neuroprotectiveandangiogenesiseffectsoflevetiracetamfollowingischemicstrokeinrats
AT renke neuroprotectiveandangiogenesiseffectsoflevetiracetamfollowingischemicstrokeinrats